|
|
|
|
3 Department of Food and Experimental Nutrition, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; 4 Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil; and 5 Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
* To whom correspondence should be addressed. E-mail: celo.tln{at}terra.com.br.
| ABSTRACT |
|---|
|
|
|---|
(TNF
) syntheses and the phagocytic and fungicidal activity of peritoneal macrophages (P < 0.05). The interaction between the +Gln diet and BCG inoculation increased the area under the curve of interleukin (IL)-1β and TNF
syntheses (P < 0.05). In conclusion, the intake of glutamine increases the function of peritoneal macrophages and hemopoiesis in early-weaned and BCG-inoculated mice. These data have important implications for the design of breast milk substitutes for human infants.
| Introduction |
|---|
|
|
|---|
20 and 2.5 times, respectively, with the progression of lactation in humans and represent >50% of the total free amino acids in human milk by mo 3 of lactation (10). In contrast to infants fed with maternal milk, early-weaned infants are deprived of this source of glutamine, which renders them exclusively dependent on endogenous synthesis of this amino acid or supplementation by means of commercially available formulas for babies (10).
Glutamine, traditionally considered a nonessential amino acid, now appears to be a conditionally essential nutrient during stress, injury, or illness (11,12). This amino acid is utilized at high rates by isolated cells of the immune system, such as macrophages, which are involved in innate immunity and whose abilities to phagocytose pathogens, kill fungi, and produce nitric oxide (NO), interleukin (IL)6-1β, IL-6, tumor necrosis factor-
(TNF
), and reactive oxygen species are dependent on the extracellular concentration of glutamine (13–19). Furthermore, glutamine plays a key role in hematopoiesis, because it acts in the proliferation and differentiation of bone marrow cells (20–22). The objective of this study was to investigate the effect of glutamine supplementation on the function of peritoneal macrophages and on hemopoiesis in early-weaned mice inoculated with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
| Methods |
|---|
|
|
|---|
All mice were generated by mating 2 2-mo-old primiparous females with a single male. After pregnancy was confirmed, the females (n = 8) were maintained isolated in individual cages throughout gestation. After the birth of their offspring, 8 males were chosen and then maintained with their mother during the next 14 d. At the moment of weaning (at the age of 14 d), 32 infant mice, 4 from each female, were distributed into 2 groups: 16 of them were fed a glutamine-free diet (–Gln), while the other 16 were fed a glutamine-supplemented diet (+Gln). Mice of the –Gln (n = 16) and +Gln (n = 16) groups consumed water and a diet made specifically for infant mice (AIN-93G) (23) ad libitum from d 14–28 (Table 1). To ensure that the diet was glutamine free, casein was substituted with a mixture of amino acids (Ajinomoto Interamericana Indústria e Comércio) in similar quantities to those found in casein, but lacking glutamine (Table 2). The amount of nitrogen corresponding to the withdrawal of glutamine (3.33 g nitrogen/kg diet) was substituted with dispensable amino acids (alanine, aspartic acid, glycine, proline, and serine), which were added to produce equivalent quantities of nitrogen. Mice from the +Gln group were also fed a casein-free diet, which was supplemented with the addition of each one of the amino acids present in the casein, plus additional glutamine (40 g glutamine/kg diet).
|
|
On d 28, the mice from the 4 groups were intraperitoneally anesthetized with ketamine hydrochloride (100 mg/kg body mass) associated with xylazine hydrochloride (50 mg/kg body mass) and then killed by cervical dislocation method. Blood, spleen, femur, liver, muscle tissue from the gastrocnemius, and peritoneal macrophages were collected for analyses. All of the mice were killed between 0800 and 1200. All procedures carried out on the mice were approved by the Ethics Committee on Animal Experimentation of the Faculty of Pharmaceutical Sciences, University of São Paulo, according to the guidelines of the Brazilian College on Animal Experimentation.
Biochemical analyses. We measured the serum corticosterone concentration was measured with a commercially available radioimmunoassay kit (DSL, Diagnostic Systems Laboratories). The plasma glutamine concentration was measured according to the method described by Lund (24). Muscle glutamine was extracted as described by Sahlin et al. (25) and glutamine concentration was determined as described by Lund (24). The maximal activity of the enzyme glutamine synthetase in the gastrocnemius muscle was determined according to Minet et al. (26).
Hematological parameters. Whole blood samples with EDTA (1 g/L, Sigma Chemical) were obtained via cardiac puncture. Total cells were quantified in a hemocytometer. Differential leukocyte counts were performed on blood smears stained by the standard May-Grumwald and Giemsa solutions (Sigma Chemical). The hematocrit levels and the concentrations of hemoglobin were determined according to Dacie and Lewis (27). Bone marrow cells were obtained by flushing the femoral cavity with McCoy's 5A medium (Sigma Chemical). The spleen was removed, placed in petri dishes containing McCoy's 5A medium with EDTA (1 g/L), and dissociated gently using needles and tweezers. Total cells were quantified using a Neubauer chamber and cytocentrifuge smears were stained with the standard May Grunwald-Giemsa solutions. Differential cell counts were performed considering 500 cells per slide per mouse.
Peritoneal cell preparation. Peritoneal macrophages were obtained by washing the peritoneal cavity with 5 mL of sterile, pyrogen- and glutamine-free RPMI 1640 medium (Cultilab), pH 7.4. In all experiments pertaining to the evaluation of the function of peritoneal macrophages, the cells obtained from mice of the 4 groups were cultivated in culture medium supplemented with 2 mmol/L glutamine. Flow cytometric analysis using a FACSCalibur flow cytometer (Becton & Dickinson) was used to determine the fraction of peritoneal F4/80+ cells labeled with the F4/80 fluorescein isothiocyanate antibody (Clone A3–1, Serotec). In all groups, the peritoneal exudate cells constituted >70% of the F4/80+ macrophages and cells adhering to the wells constituted >90% of the F4/80+ macrophages.
Cytokine and NO production by stimulated peritoneal macrophages.
Cultures rich in macrophages were obtained by incubation of 1 x 106 cells per dish in 24-well polystyrene culture plates (Falcon) for 1 h. Nonadherent cells were removed by vigorous washing 3 times with glutamine-free RPMI 1640. Adherent cells were then cultured in 1 mL fresh medium containing lipopolysaccharide (5 mg/L) from Escherichia coli strain 055:B5 (Sigma Chemical). The plates were then incubated for 2, 4, 8, and 24 h to determine the kinetics of cytokine synthesis and for 24 h to determine NO production. The concentrations of TNF
, IL-1β, IL-6, and IL-10 in the culture medium were measured using a commercially available ELISA kit (R&D Systems) according to the instructions given by the manufacturer. For the determination of NO, the production of nitrate was measured in the supernatants of cultured macrophages with a NO chemiluminescence analyzer (NOATM280, Sievers).
H2O2 production. H2O2 production by peritoneal macrophages was measured as described by Pick and Mizel (28).
Spreading and adhesion of peritoneal macrophages. The spreading ability of macrophages was estimated according to the method described by Rabinovitch and De Stefano (29). The index of spreading activity was defined as the ratio of spread cells out of 100 counted cells (29).
Phagocytosis of Candida albicans and fungicidal activity. Phagocytosis and candidacidal activity were determined according to the method described by Sasada and Johnston (30). A score was given to each macrophage according to the number of Candida cells phagocytized or killed (31).
Protein determination. Protein concentrations of macrophage preparations were measured by the method described by Bradford (32) using bovine serum albumin as a standard.
Statistical analysis. Initial body weight was expressed as means ± SEM and analyzed by 1-way ANOVA after checking the homogeneity of variances using a Bartlett test. Tukey's honestly significant difference test was applied to compare means. The effects of glutamine supplementation (diet) and inoculation with BCG were expressed as means followed by SEM and analyzed by factorial ANOVA (22) followed by Tukey honestly significant difference test. When the effects of 2 factors were taken throughout time, results were submitted to repeated-measures factorial ANOVA (diet x infection x time). Differences of P < 0.05 were considered significant. Calculations and graphics were performed using Statistica version 7.1 (StatSoft).
| Results |
|---|
|
|
|---|
Increase in hemopoiesis induced by glutamine supplementation. The leucogram showed that the glutamine-supplemented diet increased leukocyte, lymphocyte, and neutrophil counts in peripheral blood, whereas BCG inoculation led to decreased lymphocyte percentage and increased neutrophil count and percentage (Table 3). Values obtained from the erythrogram were not influenced by either diet or BCG inoculation. Glutamine supplementation led to an increase in the granulocyte and lymphocyte counts in the bone marrow and spleen. Granulocyte counts in the bone marrow were significantly higher in the +Gln/+BCG group than in the –Gln/+BCG group. The +Gln/+BCG group had increased granulocyte counts in the spleen compared with the –Gln/+BCG group, while the +Gln/–BCG group had higher granulocyte counts in the spleen than the –Gln/–BCG group.
|
synthesis of lipopolysaccharide-stimulated peritoneal macrophages. The glutamine-supplemented diet caused an increase in the area under the curve of TNF
synthesis of peritoneal macrophages (P < 0.05). The area under the curves of IL-1β (P = 0.001) and TNF
(P = 0.032) synthesis were higher in the +Gln/+BCG group than in the –Gln/+BCG group.
|
|
|
| Discussion |
|---|
|
|
|---|
The plasma glutamine concentration tended to be greater (P = 0.054) in the +Gln groups than in the –Gln groups but was not affected by BCG. Enterally administered glutamine is entirely metabolized in the splanchnic compartment and does not appear in the systemic circulation. Therefore, enterally administered glutamine will primarily affect the metabolism of the splanchnic tissue, in particular the gastrointestinal tract, its barrier function, and mucosal immunity (35). This fact may explain the possible effect of glutamine-supplemented diet on the plasma concentration of glutamine in the present study, because the presence of glutamine in the intestinal lumen causes reduced uptake of glutamine from the bloodstream by the enterocyte (36), which consequently favors an increased plasma concentration of this amino acid. This effect of glutamine supplementation by the diet may have important implications in studies involving neonates and children during acute stress and illness (35,37), given that in such situations there is a reduction in the plasma concentration of glutamine (38).
The glutamine-supplemented diet increased total nucleated cell, granulocyte, and lymphocyte counts in the bone marrow and spleen, a fact that influenced the total and differential leukocyte counts in the peripheral blood, which indicates that glutamine intake plays a key role in hematopoietic tissues of early-weaned mice. This result may be related to the fact that glutamine is essential to cell division processes, including hemopoiesis in the bone marrow, because that amino acid acts as a nitrogen donor for the biosynthesis of pyrimidines and purines (20,39,40).
In this study, the comparison between BCG-inoculated groups with regard to the functionality of peritoneal macrophages showed that the +Gln/+BCG group exhibited increased adhesion and spreading capacities, fungicidal activity, and NO, H2O2, TNF
, and IL-1β syntheses compared with the –Gln/+BCG group. These effects of glutamine supplementation are associated with metabolic alterations resulting from the BCG-induced macrophage activation process, which leads to increased glutamine metabolism, such as increased maximum glutaminase enzyme activity and glutamine consumption (41). Thus, the increased consumption of glutamine by BCG-activated macrophages suggests that the intake of glutamine through diet facilitated the activation of glutaminolysis in macrophages and, consequently, increased macrophage functional capacity in the +Gln/+BCG group compared with the –Gln/+BCG group. Similar to the results obtained in the present study concerning cytokine synthesis, other studies have demonstrated that in vivo dietary supplementation with glutamine can increase TNF
and IL-1 synthesis by thioglycollate-elicited peritoneal macrophages from mice (42) or reverse the diminished TNF
synthesis by macrophages obtained from rats fed a low-protein diet (43).
Despite the absence of significant differences in the ability to phagocytize Candida albicans, peritoneal macrophages from the +Gln/+BCG group exhibited higher fungicidal activity toward this pathogen than those from the –Gln/+BCG group. That result may be explained by the increased TNF
, H2O2, and NO syntheses from peritoneal macrophages from the +Gln/+BCG group compared with those from the –Gln/+BCG group, because these factors are crucial for killing the intracellular pathogens (44,45). The increased NO synthesis from peritoneal macrophages induced by the intake of glutamine through diet could be related to 2 mechanisms. First, stimulated macrophages would have increased arginase secretion, thus decreasing the extracellular concentration of arginine and increasing the demand for intracellular glutamine. Thus, glutamine would have acted as a precursor of arginine, because macrophages possess enzymes for the conversion of glutamine to citrulline and citrulline to arginine (46). Second, the activity of NO synthase in macrophages is dependent on NADPH and the metabolism of glutamine might have supplied NADPH by means of a catabolic pathway involving NADP+-dependent malate dehydrogenase (glutamine
glutamate
-ketoglutarate
malate
pyruvate) (19).
Glutamine, traditionally considered a nonessential amino acid, now appears to be a conditionally essential nutrient during stress, injury, or illness (12). These situations are associated with an increased susceptibility to infections and it has been suggested that this may be due in part to a diminished supply of glutamine to immunocompetent cells, such as macrophages (11,19,45). As a result, there is great interest in supplying glutamine to subjects in stress situations. Within this context, the present study showed that the intake of glutamine through diet increases the function of peritoneal macrophages in early-weaned and BCG-inoculated mice, which suggests that this amino acid may also be conditionally indispensable in the first months of life of early-weaned children with a clinical picture of infectious diseases.
In summary, this study has shown that the function of macrophages and hemopoiesis is increased by the intake of a glutamine-supplemented diet in early-weaned and BCG-inoculated mice. Thus, other studies are necessary to characterize the possible benefit of glutamine in feeding formulas for early-weaned infants to increase hematopoietic and immune responses during this phase of life.
| FOOTNOTES |
|---|
2 Author disclosures: M. M. Rogero, J. Tirapegui, M. A. Vinolo, M. C. Borges, I. A. Castro, I. S. O. Pires, and P. Borelli, no conflicts of interest. ![]()
6 Abbreviations used: BCG, bacillus Calmette-Guérin; –Gln, glutamine-free diet; +Gln, glutamine-supplemented diet; IL, interleukin; TNF
, tumor necrosis factor-
. ![]()
Manuscript received 21 February 2008. Initial review completed 4 March 2008. Revision accepted 23 April 2008.
| LITERATURE CITED |
|---|
|
|
|---|
1. Kramer MS, Kakuma R. The optimal duration of exclusive breastfeeding: a systematic review. Adv Exp Med Biol. 2004;554:63–77.[Medline]
2. Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ, Eidelman AI. American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2005;115:496–506.
3. Labbok MH, Clark D, Goldman AS. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol. 2004;4:565–72.[Medline]
4. Dewey KG, Heinig MJ, Nommsen-Rivers LA. Differences in morbidity between breast-fed and formula-fed infants. J Pediatr. 1995;126:696–702.[Medline]
5. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS, Bellagio Child Survival Study Group. How many child deaths can we prevent this year? Lancet. 2003;362:65–71.[Medline]
6. Levy J. Immunonutrition: the pediatric experience. Nutrition. 1998;14:641–7.[Medline]
7. Filteau SM. Role of breast-feeding in managing malnutrition and infectious disease. Proc Nutr Soc. 2000;59:565–72.[Medline]
8. Davis TA, Nguyen HV, Garcia-Bravo R, Fiorotto ML, Jackson EM, Lewis DS, Lee DR, Reeds PJ. Amino acid composition of human milk is not unique. J Nutr. 1994;124:1126–32.
9. Rassin DK, Sturman JA, Guall GE. Taurine and other free amino acids in milk of man and other mammals. Early Hum Dev. 1978;2:1–13.[Medline]
10. Agostoni C, Carratu B, Boniglia C, Riva E, Sanzini E. Free glutamine and glutamic acid increase in milk through a three-month lactation period. J Pediatr Gastroenterol Nutr. 2000;31:508–12.[Medline]
11. Flaring UB, Rooyackers OE, Wernerman J, Hammarqvist F. Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci. 2003;104:275–82.[Medline]
12. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990;48:297–309.[Medline]
13. Wallace C, Keast D. Glutamine and macrophages function. Metabolism. 1992;41:1016–20.[Medline]
14. Bellows CF, Jaffe BM. Glutamine is essential for nitric oxide synthesis by murine macrophages. J Surg Res. 1999;86:213–9.[Medline]
15. Yassad A, Husson A, Bion A, Lavoinne A. Synthesis of interleukin 1beta and interleukin 6 by stimulated rat peritoneal macrophages: modulation by glutamine. Cytokine. 2000;12:1288–91.[Medline]
16. Yassad A, Lavoinne A, Bion A, Daveau M, Husson A. Glutamine accelerates IL-6 production by rat peritoneal macrophages in culture. FEBS Lett. 1997;413:81–4.[Medline]
17. Murphy C, Newsholme P. Macrophage-mediated lysis of a β-cell line, TNF-
release from BCG-actived murine macrophages and IL-8 release from human monocytes are dependent on extracelular glutamine concentration and glutamine metabolism. Clin Sci. 1999;96:89–97.[Medline]
18. Costa Rosa LF, Curi R, Murphy C, Newsholme P. Effect of adrenaline and phorbol myristate acetate or bacterial lipopolysaccharide on stimulation of pathways of macrophage glucose, glutamine and O2 metabolism. Evidence for cyclic AMP-dependent protein kinase mediated inhibition of glucose-6-phosphate dehydrogenase and activation of NADP+-dependent malic enzyme. Biochem J. 1995;310:709–14.[Medline]
19. Newsholme P. Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr. 2001;131:S2515–22.
20. Dass PD, Murdoch FE, Wu MC. Glutamine promotes colony formation in bone marrow and HL-60 cells, accelerates myeloid differentiation in induced HL-60 cells. In Vitro. 1984;20:869–75.[Medline]
21. Ziegler TR. Glutamine supplementation in bone marrow transplantation. Br J Nutr. 2002;87:S9–15.[Medline]
22. Ziegler TR, Bye RL, Persinger RL, Young LS, Antin JH, Wilmore DW. Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study. Am J Med Sci. 1998;315:4–10.[Medline]
23. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition "ad hoc" writing committee on the reformulation of the AIN-76a rodent diet. J Nutr. 1993;123:1939–51.
24. Lund P. Determination of glutamine with glutaminase and glutamate dehydrogenase. In: Bergmeyer HU, Grassl M, editors. Methods of enzymatic analysis. Weinheim: Verlag Chemie, 1985. p. 1719–22.
25. Sahlin K, Katz A, Broberg S. Tricarboxylic acid cycle intermediates in human muscle during prolonged exercise. Am J Physiol. 1990;259:C834–41.[Medline]
26. Minet R, Villie F, Marcollet M, Meynial-Denis D, Cynober L. Measurement of glutamine synthetase activity in rat muscle by a colorimetric assay. Clin Chim Acta. 1997;268:121–32.[Medline]
27. Dacie JV, Lewis SM. Practical haematology. Edinburgh: Churchill Livingstone; 1995.
28. Pick E, Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods. 1981;46:211–26.[Medline]
29. Rabinovitch M, Destefano MJ. Macrophage spreading in vitro. I. Inducers of spreading. Exp Cell Res. 1973;77:323–34.[Medline]
30. Sasada M, Johnston RB. Macrophage microbicidal activity: correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophage. J Exp Med. 1980;152:85–98.
31. Sampaio SC, Sousa-e-Silva MC, Borelli P, Curi R, Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J Leukoc Biol. 2001;70:551–8.
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.[Medline]
33. Reeds PJ, Burrin DG, Davis TA, Fiorotto ML, Stoll B, Goudoever JBV. Protein nutrition of the neonate. Proc Nutr Soc. 2000;59:87–97.[Medline]
34. Yoo SS, Field CJ, Mcburney MI. Glutamine supplementation maintains intramuscular glutamine concentrations and normalizes lymphocyte function in early weaned pigs. J Nutr. 1997;127:2253–9.
35. Parimi PS, Kalhan SC. Glutamine supplementation in the newborn infant. Semin Fetal Neonatal Med. 2007;12:19–25.[Medline]
36. Windmueller HG. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol. 1982;53:201–37.[Medline]
37. Neu J. Glutamine in the fetus and critically ill low birth weight neonate: metabolism and mechanism of action. J Nutr. 2001;131:S2585–9.
38. Becker RM, Wu G, Galanko JA, Chen W, Maynor AR, Bose CL, Rhoads JM. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr. 2000;137:785–93.[Medline]
39. Bulus N, Cersosimo E, Ghishan F, Abumrad NN. Physiologic importance of glutamine. Metabolism. 1989;38:1–5.[Medline]
40. Eliasen MM, Winkler W, Jordan V, Pokar M, Marchetti M, Roth E, Allmaier G, Oehler R. Adaptive cellular mechanisms in response to glutamine-starvation. Front Biosci. 2006;11:3199–211.[Medline]
41. Costa Rosa LFBP, Safi DA, Curi R. Effect of thioglycollate and BCG stimuli on glucose and glutamine metabolism in rat macrophages. J Leukoc Biol. 1994;56:10–4.[Abstract]
42. Wells SM, Kew S, Yaqoob P, Wallace FA, Calder PC. Dietary glutamine enhances cytokine production by murine macrophages. Nutrition. 1999;15:881–4.[Medline]
43. Komatsu W, Mawatari K, Miura Y, Yagasaki K. Restoration by dietary glutamine of reduced tumor necrosis factor production in a low-protein-diet-fed rat model. Biosci Biotechnol Biochem. 2007;71:352–7.[Medline]
44. Louie A, Baltch AL, Smith RP, Franke MA, Ritz WJ, Singh JK, Gordon MA. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect Immun. 1994;62:2761–72.
45. Newsholme P, Costa Rosa LFBP, Newsholme EA, Curi R. The importance of fuel metabolism to macrophage function. Cell Biochem Funct. 1996;14:1–10.[Medline]
46. Murphy C, Newsholme P. Importance of glutamine metabolism in murine macrophages and human monocytes to L-arginine biosynthesis and rates of nitrite or urea production. Clin Sci. 1998;95:397–407.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||